A clinical and microbiological study on the enantiomers of delmopinol
Authors:
- 3 March 2016
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Odontologica Scandinavica
- Vol. 74 (5) , 355-361
Abstract
Objective The clinical part of this study aimed to investigate whether the racemate of delmopinol [(±)-delmopinol] is equivalent to its two enantiomers [(+)-delmopinol and (−)-delmopinol] with respect to efficiency and to determine and compare their pharmacokinetic properties. The purpose of the pre-clinical part was to elucidate possible differences in antimicrobial efficiency. Materials and methods The compounds were tested clinically in a double-blind, randomized, cross-over study comprising three treatment periods of 4 days each. The antimicrobial efficacy of the enantiomers was compared in vitro with respect to planktonic and biofilm bacteria of different species. Results No statistically significant differences in prevention of plaque formation were observed. Except for a somewhat higher systemic exposure in terms of AUC and Cmax indicated for (−)-delmopinol compared to (+)-delmopinol, the pharmacokinetic properties were similar. The most common adverse event was a transient anaesthetic feeling in the mouth. This event was reported with the same frequency for all three test solutions. The enantiomers showed similar antimicrobial effects on planktonic bacteria and their biofilms. Conclusions The enantiomers were found to be equally effective with respect to inhibition of plaque development and only minor differences were observed with respect to their pharmacokinetic properties. No differences could be observed in the adverse events reports. There is, therefore, no reason to use one of the enantiomers of delmopinol instead of the racemate. This was further supported by the antimicrobial tests. It is suggested that the combined action of cationic and neutral delmopinol is important for its effect on biofilms.Keywords
This publication has 32 references indexed in Scilit:
- The biofilm matrixNature Reviews Microbiology, 2010
- CHIRALITY AND PHARMACOKINETICS: AN AREA OF NEGLECTED DIMENSIONALITY?Drug Metabolism and Drug Interactions, 2007
- Meta‐analyses of studies of 0.2% delmopinol mouth rinse as an adjunct to gingival health and plaque control measuresJournal of Clinical Periodontology, 2006
- Drug disposition in three dimensions: an update on stereoselectivity in pharmacokineticsBiopharmaceutics & Drug Disposition, 2006
- Effect of local application of delmopinol hydrochloride on developing and early established supragingival plaque in humansJournal of Clinical Periodontology, 1996
- Susceptibility of biofilms of Streptococcus sanguis to chlorhexidine gluconate and cetylpyridinium chlorideOral Microbiology and Immunology, 1996
- A 6‐month home‐usage trial of 0.1% and 0.2% delmopinol mouthwashesJournal of Clinical Periodontology, 1996
- Delmopinol interactions with cell walls of gram‐negative and gram‐positive oral bacteriaOral Microbiology and Immunology, 1995
- Scanning electron microscopic observations of early plaque formation in vivo on enamel specimens treated with delmopinolJournal of Clinical Periodontology, 1993
- Effect of Delmopinol on the Viscosity of Extracellular Glucans Produced by Streptococcus mutansCaries Research, 1992